Free Trial
→ The election trade you can't lose (From Investors Alley) (Ad)

15 Healthcare Stocks that Analysts Love in a Post-Pandemic World - 12 of 15

Slide 12
Back to 11
Continue to 13
 
Back to 11
Continue to 13
 

Teva Pharmaceutical Industries (NYSE:TEVA)

Consensus Rating
Moderate Buy
Rating Score
2.8
Ratings Breakdown
7 Buy Ratings, 2 Hold Ratings, 0 Sell Ratings.
Consensus Price Target
$18.89 (7.9% Upside)

About Teva Pharmaceutical Industries

Teva Pharmaceutical Industries logoTeva Pharmaceutical Industries Limited develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, Israel, and internationally. It offers generic medicines in various dosage forms, such as tablets, capsules, injectables, inhalants, liquids, transdermal patches, ointments, and creams; sterile products, hormones, high-potency drugs, and cytotoxic substances in parenteral and solid dosage forms; and generic products with medical devices and combination products. Read More 
 

Recent Analyst Ratings

DateBrokerageActionRatingPrice TargetDetails
9/3/2024UBS GroupBoost Price TargetBuy ➝ Buy$24.00 ➝ $26.00
8/1/2024BarclaysBoost Price TargetOverweight ➝ Overweight$21.00 ➝ $22.00
7/10/2024UBS GroupBoost Price TargetBuy ➝ Buy$22.00 ➝ $24.00
7/10/2024ArgusUpgradeHold ➝ Buy$20.00
6/27/2024Jefferies Financial GroupBoost Price TargetBuy ➝ Buy$19.00 ➝ $23.00
6/5/2024BarclaysBoost Price TargetOverweight ➝ Overweight$20.00 ➝ $21.00
5/30/2024Bank of AmericaBoost Price TargetBuy ➝ Buy$18.00 ➝ $21.00
5/13/2024Piper SandlerReiterated RatingOverweight ➝ Overweight$19.00 ➝ $20.00
5/9/2024BarclaysBoost Price TargetOverweight ➝ Overweight$17.00 ➝ $20.00
3/8/2024JPMorgan Chase & Co.UpgradeUnderweight ➝ Neutral$14.00
Slide 12
Back to 11
Continue to 13
 

The election trade you can't lose (Ad)

Politics is an unpredictable game. But no matter what happens in the next few months... There's one thing that can't be stopped by anything: Dividends.

Download my Dividend Calendar here

More From MarketBeat
AI Detects Profit Surge On Monday
This has given investors the opportunity to beat the market by 1,700% and a 100% win rate to begin the year.
Monument Traders Alliance | Sponsored
7 Nuclear Energy Stocks to Buy on Growing Demand
The question isn't if nuclear energy is making a comeback, but why? There are several answers, starting with t...
MarketBeat
How the US Will Win the Great Lithium Race
China spent $60B+ on lithium infrastructure in the past decade. It possesses 7.9% of the world’s supply, but i...
DealMaker | Sponsored
7 Travel Stocks That Still Have Room to Run
There's good news and bad news for those interested in investing in travel stocks in 2024. A report from Skift...
MarketBeat
The Perfect Storm for an EV Revolt
Not many people realize there’s a "perfect storm" for profits unfolding in the auto industry - today. Globa...
Eagle Publishing | Sponsored
7 High-Yield Dividend Stocks to Beat Fixed-Income Yields
Fixed-income investments have been making a comeback. After nearly 10 consecutive years of the Federal Reserve...
MarketBeat